These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38564684)

  • 1. Concordance in Molecular Tumor Board Case Reviews in the ASCO TAPUR Study.
    Perez JK; Kleber J; Rothe M; Mangat P; Garrett-Mayer E; Schilsky RL
    JCO Precis Oncol; 2024 Mar; 8():e2300615. PubMed ID: 38564684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
    Koopman B; Groen HJM; Ligtenberg MJL; Grünberg K; Monkhorst K; de Langen AJ; Boelens MC; Paats MS; von der Thüsen JH; Dinjens WNM; Solleveld N; van Wezel T; Gelderblom H; Hendriks LE; Speel EM; Theunissen TE; Kroeze LI; Mehra N; Piet B; van der Wekken AJ; Ter Elst A; Timens W; Willems SM; Meijers RWJ; de Leng WWJ; van Lindert ASR; Radonic T; Hashemi SMS; Heideman DAM; Schuuring E; van Kempen LC
    Oncologist; 2021 Aug; 26(8):e1347-e1358. PubMed ID: 33111480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.
    Mathew A; Davis S; Boby JM; R I A; Suryavanshi M; Dawood SS; Panda PK; Nag SM; Das A; Rohatgi N; Popat S; Shah RNH; Thampy C; Parikh AR; Yadav S; Mehta P; Singh R; Mukherji D; Shilpakar R; Mullapally SK; Sirohi B
    JCO Glob Oncol; 2024 Mar; 10():e2300330. PubMed ID: 38484196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.
    Naito Y; Sunami K; Kage H; Komine K; Amano T; Imai M; Koyama T; Ennishi D; Kanai M; Kenmotsu H; Maeda T; Morita S; Sakai D; Watanabe K; Shirota H; Kinoshita I; Yoshioka M; Mamesaya N; Ito M; Kohsaka S; Saigusa Y; Yamamoto K; Hirata M; Tsuchihara K; Yoshino T
    JAMA Netw Open; 2022 Dec; 5(12):e2245081. PubMed ID: 36469316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
    Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
    Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Molecular Tumor Boards: A Systematic Review.
    Larson KL; Huang B; Weiss HL; Hull P; Westgate PM; Miller RW; Arnold SM; Kolesar JM
    JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34632252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
    Ciliberto G; Canfora M; Terrenato I; Agnoletto C; Agustoni F; Amoroso L; Baldassarre G; Curigliano G; Delmonte A; De Luca A; Fiorentino M; Gregorc V; Ibrahim T; Lazzari C; Mastronuzzi A; Pronzato P; Santoro A; Scambia G; Tommasi S; Vingiani A; Giacomini P; De Maria R
    J Exp Clin Cancer Res; 2022 Oct; 41(1):305. PubMed ID: 36245005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards.
    Rieke DT; de Bortoli T; Horak P; Lamping M; Benary M; Jelas I; Rüter G; Berger J; Zettwitz M; Kagelmann N; Kind A; Fabian F; Beule D; Glimm H; Brors B; Stenzinger A; Fröhling S; Keilholz U
    BMC Med; 2022 Oct; 20(1):367. PubMed ID: 36274133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Tumor Boards in Clinical Practice.
    Luchini C; Lawlor RT; Milella M; Scarpa A
    Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the Value of the Molecular Tumor Board: Discordance Recommendation Rate and Drug Cost Avoidance.
    Walters MK; Ackerman AT; Weese JL; Ruggeri A; Mullane MP; Hunt A; Wilson A; Ramczyk BL; Thompson MA
    JCO Precis Oncol; 2022 Oct; 6():e2200132. PubMed ID: 36265115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and Outcomes of a Molecular Tumor Board at Herbert-Herman Cancer Center, Sparrow Hospital.
    Trivedi H; Acharya D; Chamarthy U; Meunier J; Ali-Ahmad H; Hamdan M; Herman J; Srkalovic G
    Acta Med Acad; 2019 Apr; 48(1):105-115. PubMed ID: 31264438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    Mangat PK; Halabi S; Bruinooge SS; Garrett-Mayer E; Alva A; Janeway KA; Stella PJ; Voest E; Yost KJ; Perlmutter J; Pinto N; Kim ES; Schilsky RL
    JCO Precis Oncol; 2018; 2018():. PubMed ID: 30603737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a molecular tumor board at a regional level to improve access to targeted therapy.
    Bourien H; Lespagnol A; Campillo-Gimenez B; Felten-Vinot I; Metges JP; Corre R; Lesimple T; le Marechal C; Boussemart L; Kammerer-Jacquet SF; le Gall E; Denoual F; de Tayrac M; Galibert MD; Mosser J; Edeline J
    Int J Clin Oncol; 2020 Jul; 25(7):1234-1241. PubMed ID: 32215806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
    VanderWalde A; Grothey A; Vaena D; Vidal G; ElNaggar A; Bufalino G; Schwartzberg L
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33260805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.
    Sotelo-Rodríguez C; Vallejo-Ardila D; Ruiz-Patiño A; Chamorro DF; Rodríguez J; Moreno-Pérez DA; Carranza H; Otero J; Vargas C; Archila P; Rojas L; Zuluaga J; Rubio C; Ordóñez-Reyes C; Garcia-Robledo JE; Mejía S; Jaller E; Arrieta O; Cardona AF
    JCO Glob Oncol; 2024 Jan; 10():e2300011. PubMed ID: 38237094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.
    Sunami K; Naito Y; Saigusa Y; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Hirata M; Ito M; Kozuki T; Sakashita H; Horinouchi H; Okuma Y; Takashima A; Kubo T; Hironaka S; Segawa Y; Yakushijin Y; Bando H; Makiyama A; Suzuki T; Kinoshita I; Kohsaka S; Ohe Y; Ishioka C; Yamamoto K; Tsuchihara K; Yoshino T
    JAMA Oncol; 2024 Jan; 10(1):95-102. PubMed ID: 38032680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular tumor board: a tool for the governance of precision oncology in the real world.
    Incorvaia L; Russo A; Cinieri S
    Tumori; 2022 Aug; 108(4):288-290. PubMed ID: 34918610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Tumor Boards: current practice and future needs.
    van der Velden DL; van Herpen CML; van Laarhoven HWM; Smit EF; Groen HJM; Willems SM; Nederlof PM; Langenberg MHG; Cuppen E; Sleijfer S; Steeghs N; Voest EE
    Ann Oncol; 2017 Dec; 28(12):3070-3075. PubMed ID: 29045504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
    Aghamaliyev U; Karimbayli J; Giessen-Jung C; Matthias I; Unger K; Andrade D; Hofmann FO; Weniger M; Angele MK; Benedikt Westphalen C; Werner J; Renz BW
    Eur J Cancer; 2024 Jul; 205():114100. PubMed ID: 38729055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.